Immunological and pharmacological strategies to reactivate HIV-1 from latently infected cells: a possibility for HIV-1 paediatric patients?

by M. Martínez-Bonet, M.I. Clemente, M.J. Serramía, S. Moreno, E. Muñoz, M.A. Muñoz-Fernández
Published 2015-07-01

Nanotechnology against human cytomegalovirus in vitro: polyanionic carbosilane dendrimers as antiviral agents

by I. Relaño-Rodríguez, M. S. Espinar-Buitrago, V. Martín-Cañadilla, R. Gómez-Ramirez, J. L. Jiménez, M. A. Muñoz-Fernández
Published 2021-03-01

Promising PEGylated cationic dendrimers for delivery of miRNAs as a possible therapy against HIV-1 infection

by E. Royo-Rubio, I. Rodríguez-Izquierdo, M. Moreno-Domene, T. Lozano-Cruz, F. J. de la Mata, R. Gómez, M. A. Muñoz-Fernández, J. L. Jiménez
Published 2021-05-01

Increased CD127+ and decreased CD57+ T cell expression levels in HIV-infected patients on NRTI-sparing regimens

by A. Gonzalez-Serna, S. Ferrando-Martinez, L. Tarancon-Diez, R. S. De Pablo-Bernal, B. Dominguez-Molina, J. L. Jiménez, M. Á. Muñoz-Fernández, M. Leal, E. Ruiz-Mateos
Published 2017-12-01

The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children

by P. Palma, C. Foster, P. Rojo, P. Zangari, A. Yates, N. Cotugno, N. Klein, K. Luzuriaga, S. Pahwa, E. Nastouli, D.M. Gibb, W. Borkowsky, S. Bernardi, V. Calvez, E. Manno, Nadia Mora, A. Compagnucci, B. Wahren, M.Á Muñoz-Fernández, A. De Rossi, J. Ananworanich, D. Pillay, C. Giaquinto, P. Rossi
Published 2015-07-01